Matilu Mwau, M.D., MTM, D.Phil(Oxon)

Slides:



Advertisements
Similar presentations
Results of a Pilot Point-of-Care (POC) HIV Testing Program using INSTI HIV in an Urban Sexual Health Clinic in Canada Presentation to: 2007 HIV Diagnostics.
Advertisements

Preventing HIV/AIDS There is no way to tell just by looking whether a person is infected with HIV. Because people are unaware that they are HIV-positive,
Linked Testing Using Rapid HIV Tests for Antenatal Care Sentinel Surveillance in Resource-Limited Settings Evidence from Angola’s Experience in 2009 James.
HIV Testing Quality Assurance and Quality Control
Implementing Rapid HIV Testing in the United States Bernard M. Branson, M.D. Centers for Disease Control and Prevention Overview and Background.
CLINICAL TRIAL OF THE HEMA-STRIP HIV RAPID TEST USING FINGERSTICK BLOOD, WHOLE BLOOD, PLASMA, AND SERUM Niel T. Constantine 1, Dan Bigg 2, Daniel Cohen.
An Approach for a Rapid HIV Antibody Home-Use Oral Fluid Test 1 An Approach for a Rapid HIV Antibody Home-Use Oral Fluid Test OraSure Technologies, Inc.
Chronic Disease Risk Factors: 6th Grade Student Health Screenings Deanna Hanson, MSN RN, BC Beth Whitfield, BSN, RN, MAE Western Kentucky University Fall.
Module 5: Assuring the Quality of HIV Rapid Testing
New HIV Test Algorithms and Revised Adult HIV Case Report Form (DCH #1355) HIV Surveillance HIV/STD/VH/TB Epidemiology Section Bureau of Epidemiology Michigan.
Module 5: Data Collection. This training session contains information regarding: Audit Cycle Begins Audit Cycle Begins Questionnaire Administration Questionnaire.
Conducting Usability Tests 4 Step Process. Step 1 – Plan and Prep Step 2 – Find Participants Step 3 – Conduct the Session Step 4 – Analyze Data and Make.
Trinity Biotech Fingerstick whole blood sample for HIV OTC test Presented by; Fiona Campbell.
Update Rapid HIV Test Approval Requirements and Standards BPAC September 15, 2000 Kimber Poffenberger, Ph.D.
Proposed Studies to Support the Approval of Over-the-Counter (OTC) Home-Use HIV Test Kits Blood Products Advisory Committee March 10, 2006 Elliot P. Cowan,
CLIA Waiver for the OraQuick ® Rapid HIV-1 Antibody Test Elliot P. Cowan, Ph.D. Senior Regulatory Scientist Office of Blood Research and Review Center.
Status of HIV in Kenya DR Nicholas Muraguri MBChB, MPH, PGC epidemiology Head, National Aids and STI Control Program.
Developing understandable, culturally sensitive HIV self-test instructions: insights from cognitive interviewing among clients testing at two HIV testing.
1 Module 2: HIV Counseling and Testing for PMTCT Ministry of Health/HAPCO, Ethiopia.
Ethiopia Demographic and Health Survey 2011 HIV Prevalence.
Introduction to Quality Assurance. Quality assurance vs. Quality control.
Minoo Mohraz, M.D., M.P.H. Parastoo Khairandish, M.D.,M.P.H. Gholamreza Akbari, M.D. Houssien Malekafzali, M.D., Ph.D. Mohsen Malekinejad M.D., M.P.H.
Division of HIV/AIDS Managing Questionnaire Development for a National HIV Surveillance Survey, Medical Monitoring Project Jennifer L Fagan, Health Scientist/Interview.
LOW HCV PREVALENCE AMONG HIV+ INDIVIDUALS IN SUB-SAHARAN AFRICA
UNITAID PSI HIV SELF-TESTING AFRICA
Disclosure of HIV status to children living with HIV in Malawi: needs assessment and formative evaluation of an intervention to help with the disclosure.
Samia Jaffar, MPH Student Belize Cancer Center Dangriga April 2017
HIV self-testing: feasibility and acceptability of a large scale national service Cary James Head of Health Improvement Programmes Terrence Higgins Trust,
1University of Kentucky, Lexington, Kentucky
TUPEB018 Field evaluation of rapid HIV serologic tests for screening HIV-1/2 infection using serum samples from Rakai Cohort, Uganda. S.C. Kagulire, P.D.
Washington Group on Disability Statistics (WG16)
Gaps in the cascade of care in two high prevalence settings in Zimbabwe and Malawi Nolwenn Conan1, Cyrus Paye2, Erica Simons2, Abraham Mapfumo3, Tsitsi.
ASSESSMENT OF HIV PREVALENCE AND RISK BEHAVIOURS AMONG THE PRISON POPULATION IN ZIMBABWE; Adoption of the UNODC situation and needs assessment toolkit.
Government of Swaziland
Promoting male partner and couples testing through secondary distribution of self-tests by pregnant and postpartum women: a randomized trial Kawango Agot1,
What Are the Barriers to Opt-out HIV testing?
Amanda D. Castel, MD, MPH Assistant Research Professor
Introduction Results Conclusions Methods
Getting to the second 90 in adolescent HIV: What is needed
Table 1: NHBS HET3 Participant Characteristics
Developing a Methodology
David Magnuson, Trevor Hawkins, Robertino Mera
Micro-level Social and Structural Syndemic of HIV Risk among Nepalese Female Sex Workers Keshab Deuba, Sarah Anderson, Anna Mia Ekström, Satish Raj Pandey,
Unigold Recombigen HIV 1/2 Training for HIV Testing Sites
Acute HIV Infection and PrEP: Opportunities and challenges
San Francisco Department of Public Health
INTEGRATING HIV AND HCV TESTING.
Warm up – Unit 4 Test – Financial Analysis
MoH leading the design and scale up of PrEP in eswatini
Exam Room Health Center Health Center Front Desk Waiting Room
Hazel Ann Moore, MB ChB, MFam Med
IMPLEMETNATION OF PrEP IN SRH SETTINGS (OR CLIMBING A MOUNTAIN)
The Scientific Method.
The Scientific Method.
The Scientific Method.
AIDS in the United States
Roles of District Community-Directed Intervention (CDI) Team Members
Sociological Research Methods
The Vermont Young Adult Survey: Methods and Some Initial Findings
Chaney et al.’s funhaler study (2004)
Rapid-Rapid Point of Care Testing
Utilization of Audio visual medium for conveying sputum collection instructions for tuberculosis diagnosis Presenter: Fred ORINA.
Indicator 3.05 Interpret marketing information to test hypotheses and/or to resolve issues.
TRACE INITIATIVE: Data Collection Tools and Forms
Dr. Magdalene Kuria April 2019 Kenya Pediatric Association Conference
HIV Testing in the U. S. Julie Saber Galen College of Nursing
About bioLytical Laboratories
Overview of the POC EID Training Toolkit
Kristen M. Little, Christine Odour, Heather Awsumb, Hildah Essendi
Performance of mPima for quantification of HIV Viral load for pregnant and post-partum woman in primary health care clinics in Mozambique Team: B. Meggi.
Presentation transcript:

Matilu Mwau, M.D., MTM, D.Phil(Oxon) Performance and usability of INSTI, a blood-based rapid HIV self test for qualitative detection of HIV antibodies in intended use populations in Kenya Matilu Mwau, M.D., MTM, D.Phil(Oxon) mmwau@kemri.org

Kenya in 2015 Kenya 1.5 million PLWHIV 5.9% adult HIV prevalence Some counties >25% eg Homa Bay 78,000 new infections 58% of infected adults are on ART 83% HIV+ unaware of partners’ status May, 2017, PrEP approved -“Be Self Sure” HIV self testing program

Study Objectives Determine the performance and usability of the INSTI blood-based HIV self test (bioLytical Laboratories, Richmond, BC, Canada) for an intended-use self test population in Kenya. Device performance Label comprehension Readability Results interpretation

INSTI HIV Self Test Key Features Same platform as INSTI HIV-1/HIV-2 Ab Test Blood-based Use a 50uL free-flowing blood drop fingerstick collection Sensitivity 100% Specificity 99.8% 4

Procedure (English and Swahili) INSTI Self Test Procedure (English and Swahili) Sample. Pour. 60s 5

Study site and design Site: Western Kenya (Busia County) Matayos, Bumutiru,Khunyangu, Aterait and Asinge villages Time: 22nd Mar -11Apr 2017 688 study participants 554 consented for fingerstick and venous blood draws 134 consented for fingerstick only 354 participated in the label comprehension (usability) study 91 subjects completed the results interpretation study

Accuracy (1) Fingerstick blood used for observed self testing 476 participants completed accuracy study 201 known HIV positive. Demographics, > 18 years of age, able to provide informed consent, able to read, write and speak English/Swahili Fingerstick blood used for observed self testing Venous blood sent to KEMRI Lab for Bioelisa HIV-1+2 Ag/Ab kit (Biokit S.A, Barcelona, Spain) INSTI HIV Self Test results produced by subjects Self Test results interpreted and recorded by HCW

Accuracy (2) Subject HIV Status INSTI Negative Positive Total 267 2 269 3 198 201 Invalid 6 6* 270 206 476 INSTI Sensitivity: 198/201 = 98.5% (95.7-99.5%) INSTI Specificity: 267/269 = 99.26% (97.3-99.8%) * Invalid results not used in the calculations

Usability Results (n=350) Observed IFU Element Subject Completed Correctly Preparation of finger fingerstick 346 (98.9%) Correct use of lancet with no assistance 291 (83.1%) Correct use of lancet with assistance 58 (16.6%) Able to form “hanging” blood drop on finger with no assistance 348 (99.4%) Able to easily get the blood drop to fall into INSTI sample diliuent 349 (99.7%) Properly mixed and added sample diluent/blood to INSTI blotted membrane unit Correctly completed remaining INSTI test procedure University: 22. Secondary: 123. Primary. 152. No formal education. 48. Not recorded. 5. 354 participants were recruited and 350 completed the survey-based usability, label comprehension and ease of use elements as observed and recorded by the health care staff

Acceptability (n=350) Questionnaire Item Responses Used the INSTI instructions for use to perform the test 343 (98.0%) Found instructions easy to comprehend 339 (96.9%) Considered the INSTI test easy to perform 330 (94.3%) Found results interpretation easy to comprehend 342 (97.7%) Indicated willingness to use INSTI again Would recommend INSTI to partner, family 344 (98.3%)

INSTI Results Readability(n=91) Correct Interpretation (n=91) Strong Positive 91 (100%) Weak Positive 31 (34.1%)* Negative Invalid (no control spot) Subjects were asked to interpret a range of INSTI results using the IFU for contrived membrane cartridges representing strong positive, weak positive, negative and invalid results. * The remaining 65.9% of subjects saw the weak spot but were unsure on how to interpret the result

Conclusions INSTI PPV=89.3%, INSTI NPV=99.9% Based on the performance of the INSTI HIV Self Test in this study HIV prevalence in Kenya of 5.9%: INSTI HIV Self Test device performance meets the Kenya MoH threshold. Overall label comprehension is high (96.9%) 57.1% of participants had primary or no formal education. In the usability study, more males (206) than females (142) took part likely due to the use of county administration and village events to mobilize participants Poor interpretation for the weak positive result ? discordance in the IFU image between the English and Swahili versions. The manufacturer has revised the IFU to provide more clear instructions on weak positive interpretation.

Acknowledgements Priska Bwana Lydia Ochieng Alupe HIV Lab KEMRI HQ HIV Lab